title: Comparison of efficacies of bovine immune colostral antibody and each immunoglobulin class against verotoxin 2, flagellum and somatic cells of Escherichia coli O157:H7 in mice.
abstract: OBJECTIVE
  The efficacy of bovine immune colostral (colostral) antibodies against verotoxin (VT) 2, flagellum and somatic cells of Escherichia coli (E. coli) O157:H7 in mice was determined.
  
  
  METHODS
  Three major immunoglobulin (Ig) classes were isolated from the colostral antibody against VT2 by affinity chromatography and were used for estimation. Mice inoculated with VT2 were administered each Ig class from the colostral antibody, colostral antibody (colostral whey containing antibody) or serum antibody against VT2 at 1 hour after VT2 inoculation.
  
  
  RESULTS
  All control mice (20/20) died after administration of sterilized saline instead of the colostral antibody. The survival rate was 93.3% (14/15) after administration of S-IgA or IgM antibody, or colostral antibody. Survival rates for IgG antibody and serum antibody administration were 80% (12/15) and 60% (9/15), respectively. Serum concentrations of VT2, which was absorbed from the small intestine in mice after administration of VT2 and colostral antibody, were measured by fluorescence enzyme immunoassay (FEIA). Serum concentrations of VT2 after administration of colostral antibody were lower than those after administration of sterilized saline. Mice inoculated with VT2-producing E. coli 157:H7 were administered anti-flagellum or anti-somatic colostral antibodies. Survival rates for E. coli O157:H7-infected mice administered the anti-flagellum and anti-somatic colostral antibodies were 52.4% (11/21) and 22.2% (4/18), respectively. Furthermore, survival rates increased to 89.5% (17/19) with combined administration of anti-flagellum and anti-VT2 colostral antibodies.
  
  
  CONCLUSIONS
  These results suggest that colostral antibodies against VT2, flagellum and somatic cells are effective against E. coli O157:H7 infection.
authors.affiliation: Laboratory of Immunology, School of Life and Environmental Science, Azabu University, Kanagawa, Japan.
authors.forename: Tetsurou
authors.initials: T
authors.lastname: Seita
authors.forename: Takashi
authors.initials: T
authors.lastname: Kuribayashi
authors.forename: Toshio
authors.initials: T
authors.lastname: Honjo
authors.forename: Shizuo
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D002417:Cattle; D002846:Chromatography, Affinity; D003126:Colostrum / Q000276:immunology*; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000517:prevention & control; D019453:Escherichia coli O157 / Q000276:immunology*; D005260:Female; D005407:Flagella / Q000276:immunology*; D007136:Immunoglobulins / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D051379:Mice; D011041:Poisoning / Q000517:prevention & control; D011247:Pregnancy; D022641:Shiga Toxin 2 / Q000276:immunology*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000907:Antibodies, Bacterial; D007136:Immunoglobulins; D022641:Shiga Toxin 2